What is N1-Methyl Nicotinamide? N1-Methyl Nicotinamide (NMN) is a metabolite of nicotinic acid (vitamin B3 or niacin) and nicotinamide, formed during the metabolism of these compounds in the body. It is excreted in urine and serves as a biomarker to assess niacin status, liver function, and metabolic health. Measuring NMN levels can help evaluate nutritional deficiencies or monitor the effects of niacin supplementation.
Definition: The N1-Methyl Nicotinamide Unit Converter converts NMN concentrations between various units, enabling standardization of laboratory results for clinical and research use.
Purpose: It assists clinicians, nutritionists, and researchers in interpreting NMN levels across different measurement units (e.g., nmol/L to ng/mL), ensuring accurate assessment of niacin metabolism and related health conditions.
Converting NMN concentrations between units is critical for:
Elevated Levels: High NMN levels may indicate excessive niacin intake or supplementation, while low levels can suggest niacin deficiency (e.g., pellagra) or impaired liver metabolism.
Normal Ranges:
Interferences:
Q: Why are there different units for NMN?
A: Different units reflect varying standards; nmol/L is the SI unit, while ng/mL and µg/L are commonly used in clinical and research settings.
Q: What is a normal NMN level?
A: Normal urinary NMN is typically 0.5–8.0 µg/mL (3.6–58.3 nmol/L). Levels vary by sample and context—consult a healthcare provider for interpretation.
Q: Can this converter be used for other metabolites?
A: No, this converter is specific to NMN; other metabolites have different conversion factors—consult a healthcare provider for accuracy.